Author: OurCrowd

[Alpha Tau in Globe Newswire] Alpha Tau announces receipt of radioactive material license for its New Hampshire manufacturing facility, advancing towards commercial readiness

Oct 21, 2025 |

JERUSALEM, Oct. 21, 2025 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT® announced today that it has secured a radioactive material license from the State of New Hampshire Bureau of Public Health Protection, Radiological Health Section, following completion of the first phase of construction of its commercial-scale manufacturing facility in Hudson, New Hampshire. Read...

Read More

[BioCatch in Calcalist] “It’s not a market that is easily penetrated”: Inside the quiet boom of Israel–Australia innovation ties

Oct 21, 2025 |

“Australia leads the world in detection of scams and we do have part in that,” says Gadi Mazor, CEO of Israeli AI-driven behavioral biometrics company BioCatch. BioCatch is one of the success stories that captures the deepening bilateral business ties between Israel and Australia. Since entering the market in 2018, the company’s behavioral fraud-detection technology has been adopted by all four of Australia’s major banks, representing roughly 85% of the national banking market, according to Mazor. Read...

Read More